ANGANY
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
873 Rue Saint-Jean Suite 200, Quebec, Qu...Phone Number
+33 232590580Website
www.angany.comRevenue
<$5 MillionIndustry
About ANGANY
ANGANY is a private clinical-stage biotechnology company focused on developing innovative allergy therapeutics aimed at helping individuals with allergic asthma build a protective immune response against specific allergens. Their proprietary platform utilizes synthetic biology and a unique self-adjuvant vector, the eBioparticle, to restore immune tolerance and sustainably treat allergies. With a commitment to improving the lives of asthma sufferers, ANGANY's technology has shown promising results in clinical studies, particularly for cat allergy-related asthma. The company also applies its advanced biotechnology to other health fields, including animal health and cancer.Explore more
ANGANY Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to ANGANY
Compare insights from companies similar to ANGANY, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ANGANY Tech Stack
A closer look at the technologies used by ANGANY
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding ANGANY
Sign Up For FreeTo access detailed company insights
ANGANY is a private clinical-stage biotechnology company focused on developing innovative allergy therapeutics aimed at helping individuals with allergic asthma build a protective immune response against specific allergens. Their proprietary platform utilizes synthetic biology and a unique self-adjuvant vector, the eBioparticle, to restore immune t... Read More
